about
Influence of Resistance Training on Neuromuscular Function and Physical Capacity in ALS Patients.Carbohydrate restricted recovery from long term endurance exercise does not affect gene responses involved in mitochondrial biogenesis in highly trained athletes.Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study.Blood flow restricted training leads to myocellular macrophage infiltration and upregulation of heat shock proteins, but no apparent muscle damage.Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels.Physical function and muscle strength in sporadic inclusion body myositis.Effects of blood-flow-restricted resistance training on muscle function in a 74-year-old male with sporadic inclusion body myositis: a case report.Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial.Delayed Effect of Blood Flow-restricted Resistance Training on Rapid Force Capacity.Proliferation of myogenic stem cells in human skeletal muscle in response to low-load resistance training with blood flow restrictionLean body mass and muscle function in head and neck cancer patients and healthy individuals--results from the DAHANCA 25 studyEffect of blood-flow restricted vs heavy-load strength training on muscle strength: Systematic review and meta-analysisCorrigendum: Blood Flow Restriction Exercise: Considerations of Methodology, Application, and SafetyAgeing of human skeletal muscle - myofibre reinnervation as a protective determinant of age-related loss of physical functionThe immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise trainingBlood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
P50
Q33741341-D02E6B5E-7DD6-4627-A463-75237BF33D26Q35363410-FB6358FE-7FDC-4AAA-8D49-6731CBCA892FQ38383849-2C3639B7-7E7F-47AB-A20E-7F8437A8FE01Q38686588-6B31ECDA-56DC-4B03-8B7A-15F4B2A54508Q43735624-6ECF9956-651D-470A-B927-5AACFDF3CEFFQ47576235-2D982FFC-2724-454E-A4E5-F0E0CBDF487AQ48053957-D879BECF-4B98-40E5-AA91-BF263FD1ECEAQ48189402-59661D97-23D5-47FB-835B-FB14265A3118Q50932936-E240B56B-6041-462E-95A9-16BCCBA5501BQ84579023-5C59B9F6-12D2-4698-AC4B-95CD37C7B057Q87289278-11D67630-3CCF-4AC0-ABC9-FEB879390A08Q89591910-2583E3DB-F0D4-4718-A765-32D68C750D0DQ91154038-A4E285DD-E857-4D4B-839C-A8739ABD03CAQ91460069-F9EAF46D-2E14-451B-8A0B-C4C9BFDE986EQ92091410-7A62C18D-A4F1-4FD7-8770-AD0A0A545E39Q92478311-FE0EB4C6-F292-4D17-BAA5-9CA1A6460A6E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jakob L Nielsen
@ast
Jakob L Nielsen
@en
Jakob L Nielsen
@es
Jakob L Nielsen
@nl
type
label
Jakob L Nielsen
@ast
Jakob L Nielsen
@en
Jakob L Nielsen
@es
Jakob L Nielsen
@nl
altLabel
Jakob Nielsen
@en
prefLabel
Jakob L Nielsen
@ast
Jakob L Nielsen
@en
Jakob L Nielsen
@es
Jakob L Nielsen
@nl
P106
P1153
55751859300
P31
P496
0000-0003-0979-4647